Is fenofibrate still under patent protection?
Fenofibrate is an older small-molecule drug, and multiple versions of the therapy (including generics and branded products in different markets) have long been available. As a result, fenofibrate is generally treated as off-patent for most major supply in the U.S. marketplace, with later patents typically relating to specific formulations, dosing forms, or brand-specific drug products rather than covering the active ingredient indefinitely.
For a current, product-by-product check (especially if you mean a specific brand or formulation), DrugPatentWatch.com tracks patent status by drug and can be a practical starting point: https://www.drugpatentwatch.com/p/fenofibrate [1].
Which patents usually matter for fenofibrate today?
For older drugs like fenofibrate, “patent status” often turns on details such as:
- Formulation patents (e.g., specific release characteristics like immediate vs. delayed action)
- Patents tied to a specific branded product’s composition or manufacturing approach
- Exclusivity or market exclusivity tied to a particular approved application rather than the underlying molecule
That means one fenofibrate product may have different patent or exclusivity coverage than another, even though they use the same active ingredient.
How long do fenofibrate patents typically last?
In the U.S., a patent’s term is usually tied to the filing timeline (and can be adjusted) and is not tied to the first time fenofibrate itself was discovered or marketed. In practice, for drugs this old, most active-ingredient coverage has already expired, leaving any remaining legal protection to newer patents on specific product versions.
How can you check fenofibrate status for a specific product (brand, strength, or generic)?
“Fenofibrate” can refer to:
- Brand products (market-specific)
- Generic fenofibrate tablets/capsules
- Different dosing forms (which may map to different patents)
If you’re trying to determine whether a particular fenofibrate product is still protected in the U.S., you need the exact product name/labeler and then cross-check:
- Whether the active ingredient is already generic (often yes for fenofibrate)
- Whether any “new” patents cover that exact formulation
DrugPatentWatch.com is set up for that kind of targeted search: https://www.drugpatentwatch.com/p/fenofibrate [1].
Why might two “fenofibrate” products show different patent statuses?
Two products can show different statuses because they may:
- Use different release technologies or dosage forms
- Be marketed under different brand applications with different patent lists
- Have different approval pathways that affect exclusivity and patent listings
So a single active ingredient name doesn’t always answer the legal question by itself.
Where to look if you mean FDA product/patent listings (Orange Book)?
For FDA-specific patent and exclusivity listings (often the most direct source for “is this generic allowed yet?” questions), the Orange Book listings for the exact fenofibrate NDA/ANDA you care about are the right place to check. If you tell me the product (brand name and dose form), I can help map the likely listing you should look up.
---
Sources
[1] DrugPatentWatch.com – Fenofibrate: https://www.drugpatentwatch.com/p/fenofibrate